AU738192B2 - Neuronal rescue agent - Google Patents

Neuronal rescue agent Download PDF

Info

Publication number
AU738192B2
AU738192B2 AU93684/98A AU9368498A AU738192B2 AU 738192 B2 AU738192 B2 AU 738192B2 AU 93684/98 A AU93684/98 A AU 93684/98A AU 9368498 A AU9368498 A AU 9368498A AU 738192 B2 AU738192 B2 AU 738192B2
Authority
AU
Australia
Prior art keywords
activin
neurons
insult
patient
neuronal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU93684/98A
Other languages
English (en)
Other versions
AU9368498A (en
Inventor
Peter David Gluckman
Paul Edmund Hughes
Maggie Lai
Christopher Edward Williams
Dahao Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEUREN PHARMACEUTICALS Ltd
Original Assignee
Auckland Uniservices Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auckland Uniservices Ltd filed Critical Auckland Uniservices Ltd
Publication of AU9368498A publication Critical patent/AU9368498A/en
Application granted granted Critical
Publication of AU738192B2 publication Critical patent/AU738192B2/en
Assigned to NEURONZ LIMITED reassignment NEURONZ LIMITED Alteration of Name(s) in Register under S187 Assignors: AUCKLAND UNISERVICES LIMITED
Assigned to NEUREN PHARMACEUTICALS LIMITED reassignment NEUREN PHARMACEUTICALS LIMITED Alteration of Name(s) in Register under S187 Assignors: NEURONZ LIMITED
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU93684/98A 1997-09-19 1998-09-18 Neuronal rescue agent Ceased AU738192B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ32879697 1997-09-19
NZ328796 1997-09-19
PCT/NZ1998/000139 WO1999015192A1 (fr) 1997-09-19 1998-09-18 Agent de sauvetage neuronal

Publications (2)

Publication Number Publication Date
AU9368498A AU9368498A (en) 1999-04-12
AU738192B2 true AU738192B2 (en) 2001-09-13

Family

ID=19926449

Family Applications (1)

Application Number Title Priority Date Filing Date
AU93684/98A Ceased AU738192B2 (en) 1997-09-19 1998-09-18 Neuronal rescue agent

Country Status (2)

Country Link
AU (1) AU738192B2 (fr)
WO (1) WO1999015192A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928311D0 (en) 1999-11-30 2000-01-26 Novartis Ag Organic compounds
US7714020B2 (en) 2001-05-24 2010-05-11 Neuren Pharmaceuticals Limited Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
US7605177B2 (en) 2001-05-24 2009-10-20 Neuren Pharmaceuticals Limited Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration
DE60232880D1 (de) 2001-05-24 2009-08-20 Neuren Pharmaceuticals Ltd Gpe-analoga und peptidomimetika
US20030103959A1 (en) * 2001-06-22 2003-06-05 Hughes Paul E. Methods of providing neuroprotection and/or neurorestoration via the neural activin type IIB receptor
US9271904B2 (en) 2003-11-21 2016-03-01 Intercontinental Great Brands Llc Controlled release oral delivery systems
ES2426005T3 (es) * 2004-07-23 2013-10-18 Acceleron Pharma Inc. Polipéptidos del receptor ACTRII, procedimientos y composiciones
WO2006108651A2 (fr) * 2005-04-12 2006-10-19 Develogen Aktiengesellschaft Utilisation de produits de l'activine pour prevenir et/ou traiter le diabete et/ou le syndrome metabolique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4019208A1 (de) * 1990-06-15 1992-03-05 Peter Dr Med Wehling Nervenregenerationsmittel

Also Published As

Publication number Publication date
AU9368498A (en) 1999-04-12
WO1999015192A1 (fr) 1999-04-01

Similar Documents

Publication Publication Date Title
Meethal et al. The role of hypothalamic-pituitary-gonadal hormones in the normal structure and functioning of the brain
Hughes et al. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease
Ma et al. Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems
Azmitia et al. S-100B but not NGF, EGF, insulin or calmodulin is a CNS serotonergic growth factor
US20040038888A1 (en) Functional role and potential therapeutic use of PACAP, VIP and Maxadilan in relation to adult neural stem or progenitor cells
Waschek Vasoactive intestinal peptide: an important trophic factor and developmental regulator?
US20090136481A1 (en) Use of Myostatin (GDF-8) Antagonists for Treatment of Sarcopenia (Age-Related Muscle-Wasting)
Burke et al. Loss of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus: rescue by neurotrophins
US20070190056A1 (en) Muscle regeneration compositions and uses therefor
US7304029B1 (en) Neuroprotective effect of growth hormone
Martinez-Moreno et al. Growth hormone protects against kainate excitotoxicity and induces BDNF and NT3 expression in chicken neuroretinal cells
WO2003039575A2 (fr) Role fonctionnel et utilisation therapeutique potentielle de proteines s, gas6 et reelin en relation avec des cellules souches neuronales adultes
Liu et al. Effects of sialoadenectomy and epidermal growth factor on testicular function of sexually mature male mice
AU738192B2 (en) Neuronal rescue agent
Darland et al. Activin A and follistatin expression in developing targets of ciliary ganglion neurons suggests a role in regulating neurotransmitter phenotype
US20070015707A1 (en) Neuroprotective effect of activin in animals exposed to hypoxia/ischemia
Köves et al. Advent and recent advances in research on the role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the regulation of gonadotropic hormone secretion of female rats
Kuwahara-Otani et al. Interleukin-18 and its receptor are expressed in gonadotropin-releasing hormone neurons of mouse and rat forebrain
US20030103959A1 (en) Methods of providing neuroprotection and/or neurorestoration via the neural activin type IIB receptor
JOOSTEN et al. Alpha-melanocyte stimulating hormone promotes regrowth of injured axons in the adult rat spinal cord
EP0755682A1 (fr) Méthodes de traitement de maladies des neurones moteurs utilisant des éléments de la famille des molécules BDNF/NT-3/NGF
D’Angelo et al. Nerve growth factor in the adult brain of a teleostean model for aging research: Nothobranchius furzeri
Ferri et al. vgf A neurotrophin-inducible gene expressed in neuroendocrine tissues
Khan et al. Steroidogenesis-inducing protein promotes deoxyribonucleic acid synthesis in Leydig cells from immature rats.
Vadakkadath Meethal et al. Alzheimer’s disease: the impact of age-related changes in reproductive hormones: The role of hypothalamic-pituitary-gonadal hormones in the normal structure and functioning of the brain

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)